Results 271 to 280 of about 295,251 (340)

The effect of severe renal impairment on the pharmacokinetics, safety and tolerability of balcinrenone

British Journal of Clinical Pharmacology, EarlyView.
Aims The aim of this phase 1 trial was to assess the pharmacokinetics, safety and tolerability of balcinrenone (previously AZD9977) in participants with severe renal impairment vs. those with normal renal function. Methods Participants with severe renal impairment (estimated glomerular filtration rate [eGFR] < 30 mL/min/1.73 m2) not on dialysis were ...
Chandrali S. Bhattacharya, Hans Ericsson, Susanne Johansson, Joanna Parkinson, Simina M. Boca, Ye Yang, Maria Heijer, Greggory Housler, Maria Leonsson‐Zachrisson, Judith Hartleib‐Geschwindner, Patricia Ely Pizzato   +10 more
wiley   +1 more source

The impact of mindfulness meditation on pro-inflammatory biomarkers in patients with end-stage renal disease: A randomized trial. [PDF]

SAGE Open Med
Alhawatmeh H, Najadat I, Hweidi I, Abuhammad S.   +3 more
europepmc   +1 more source

Assessment of ethnic differences in pharmacokinetics and clinical responses of acalabrutinib between Chinese and White patients with B‐cell malignancies

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims The aim of this study was to assess differences between Chinese and White patients in pharmacokinetics (PK) of, and clinical response to, acalabrutinib and its pharmacologically active major metabolite, ACP‐5862, to support recommended dosing in Chinese patients with B‐cell malignancies.
Tingting Yao, Junjie Ding, Shringi Sharma, Yunfei Li, Qianwei Xu, Peiming Ma   +5 more
wiley   +1 more source

Hand Infections in End-Stage Renal Disease-Consider Tumoral Calcinosis. [PDF]

J Hand Surg Glob Online
Goza SD, Lebhar MS, Sullivan JM, Waetjen E, Walker ME.   +4 more
europepmc   +1 more source

Phosphate Binder Impairs Levothyroxine Absorption in a Hypothyroid Patient With End-Stage Renal Disease. [PDF]

Cureus
Ko M, Barai R, Brent G.
europepmc   +1 more source

Effect of hybrid blood purification on nutritional status, inflammation, and cardiovascular events in patients with end-stage renal disease. [PDF]

Pak J Med Sci
Fei L, Li H, Zhang B, Li C, Zou R.
europepmc   +1 more source

Cutaneous manifestations of dialysis-associated steal syndrome in a patient with end-stage renal disease. [PDF]

JAAD Case Rep
Blegen K, Niazi M, Pruneda C, Tarbox M.
europepmc   +1 more source

Effectiveness of phosphate binders on mortality and cardiovascular disease in end-stage renal disease patients with hyperphosphatemia: a multicenter real-world cohort study. [PDF]

BMC Nephrol
Chaiyakittisopon K, Pattanaprateep O, Ponthongmak W, Kunakorntham P, Chuasuwan A, Ingsathit A, Mckay GJ, Attia J, Thakkinstian A.   +8 more
europepmc   +1 more source

Acceptance of Illness and Health Behaviours of Patients with End-Stage Renal Disease Treated with Haemodialysis: A Single-Centre Study. [PDF]

Healthcare (Basel)
Hreńczuk MK, Rudnicka W, Piątek TD, Małkowski P.   +3 more
europepmc   +1 more source

Predicting In-Hospital Mortality in Patients with End-Stage Renal Disease Receiving Extracorporeal Membrane Oxygenation Therapy.

Cardiorenal Med
Tsai TY, Fan PC, Lee CC, Chen SW, Chen JJ, Chan MJ, Fang JT, Chen YC, Chang CH.   +8 more
europepmc   +1 more source